HLA Typing for Transplant market is expected to grow from USD 0.68 billion in 2019 to USD 1.10 billion by 2026 at a CAGR of 7% from 2020 to 2026.
HLA typing recognizes the exceptional group of HLA antigens for an individual. Documentation of HLA-class I and sophistication II antigens are administered by molecular diagnostic procedures supported DNA. HLA typing utilizing these advanced DNA innovations and provides more vigorous, accurate testing results that are reliable in identifying difference in HLA genes However, unfavorable reimbursement policies for organ transplantation and donation procedures and high cost of polymerase chain reaction-based technological devices hamper the expansion of the market. Furthermore, a shift in technology from serological assays to HLA profiling which is gene-based, and advancements in health care facilities across emerging countries present significant opportunities for HLA typing transplant players within the market. An important gap between the number of organ donors and therefore the number of organs that are required annually restrains the worldwide HLA typing transplant diagnostic services market. The global market is segregated on the basis of Technology as Molecular Assay Technologies and Non-molecular Assay Technologies. Based on Product and Service the global market is segmented in Reagents & Consumables, Instruments, and Software & Services. Based on End User the global market is segmented in Independent Reference Laboratories, Hospitals & Transplant Centers, and Research Laboratories & Academic Institutes. The report also bifurcates the global market based on Application in Diagnostic Applications and Research Applications.
The global market report provides geographical analysis covering regions, such as Europe, North America, Asia Pacific, and the Rest of The World. The market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Thermo Fisher Scientific, Hoffman-La Roche Limited, Qiagen, Immucor, Abbott Laboratories Inc., Caredx, Inc., Illumina, Bio-Rad Laboratories, Alpha Biotech, Ltd., Genex, and others are among the major players in the market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
The global HLA Typing for Transplant market has been segmented as below:
By Technology
By Product and Service
By End-User
By Application
By Region
By Company
The report covers the below scope:
The years considered for the study are as follows:
Report Scope:
The global market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers the analysis of regional and country-level market dynamics. The scope also covers a competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the market share. Major industry players with significant revenue share include Thermo Fisher Scientific, Hoffman-La Roche Limited, Qiagen, Immucor, Abbott Laboratories Inc., Caredx, Inc., Illumina, Bio-Rad Laboratories, Alpha Biotech, Ltd., Gendx, and others.
Why Buy this Report:
Target Audience:
The report targeted the existing players in the industry is as follows:
Free and Paid Customization based on the requirement
Report Content
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
5.1 Introduction
5.2 Molecular Assay Technologies
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Non-molecular Assay Technologies
5.3.1 Market Overview
5.3.2 Market Size and Forecast
6.1 Introduction
6.2 Reagents & Consumables
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Instruments
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Software & Services
6.4.1 Market Overview
6.4.2 Market Size and Forecast
7.1 Introduction
7.2 Independent Reference Laboratories
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Hospitals & Transplant Centers
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Research Laboratories & Academic Institutes
7.4.1 Market Overview
7.4.2 Market Size and Forecast
8.1 Introduction
8.2 Diagnostic Applications
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Research Applications
8.3.1 Market Overview
8.3.2 Market Size and Forecast
9.1 Introduction
9.2 Europe
9.2.1 Europe Market, By Technology
9.2.2 Europe Market, By Product and Service
9.2.3 Europe Market, By End User
9.2.4 Europe Market, By Application
9.3 North America
9.3.1 North America Market, By Technology
9.3.2 North America Market, By Product and Service
9.3.3 North America Market, By End User
9.3.4 North America Market, By Application
9.4 Asia Pacific
9.4.1 Asia Pacific Market, By Technology
9.4.2 Asia Pacific Market, By Product and Service
9.4.3 Asia Pacific Market, By End User
9.4.4 Asia Pacific Market, By Application
9.5 Rest of The World
9.5.1 Rest of The World Market, By Technology
9.5.2 Rest of The World Market, By Product and Service
9.5.3 Rest of The World Market, By End User
9.5.4 Rest of The World Market, By Application
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
(Overview, Key Financials, Product and Service Offering, Recent Developments)
The global HLA Typing for Transplant market has been segmented as below:
By Technology
By Product and Service
By End User
By Application
By Region
By Company